CU Boulder, UCLA study finds COVID-19 protective measures saved 800,000 lives
Covid Lists
Long covid may cause cognitive decline of about six IQ points, study finds
Even fully recovered survivors of mild COVID can lose IQ points, study suggests | CIDRAP
Exclusive: Study Finds COVID Harmed Cognitive Skills of Students — and Teachers
Pandemic Mitigation Collaborative - COVID-19 Forecasting Model
R&D for long COVID is collapsing
Analysis reveals global post-covid surge in infectious diseases
Public Service Announcement - WHN
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination
UT researchers say they found an antibody that protects against all COVID-19 variants
Scientists Develop Game-Changing Needle-Free COVID-19 Intranasal Vaccine
COVID-19 Update: An EUA for Pemivibart (Pemgarda) for Pre-Exposure Prophylaxis | The Medical Letter Inc.
Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19
Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19
NasalCrom for Neuroinflammation?
Study: Long COVID affects 8% of those with COVID-19, is more common in women
Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition
Researchers identify amino acid that may play a key role for predicting and treating long COVID
Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study
From a Grassroots Survey to Long Covid Treatment Trials
Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other Considerations
Narrative Service
Americans Don’t Get to Have the Best New COVID Drug
Further patients benefit from drug against Long COVID
Long COVID: Study Says Synbiotic Drug That Alters Gut Microbiome Relieves Multiple Symptoms
NIH Launches Trials for Long COVID Treatment Breakthroughs
Intravenous immunoglobulin as a potential treatment for long COVID
Large Review Suggests IVIG is Effective for Neurological Diseases Following COVID-19 Infection
Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review - PubMed